BioCentury
ARTICLE | Company News

Alexza drug delivery, neurology news

October 19, 2015 7:00 AM UTC

Alexza retained Guggenheim Securities to explore strategic options, including the sale or disposition of one or more corporate assets, a strategic business combination, partnership or other transactio...